| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |